Imbruvica comes in three forms that are swallowed: a tablet, a capsule, and a liquid suspension (a type of liquid mixture). Imbruvica is also available in several different strengths. To find out ...

Acerta has no drugs on the market yet, but its lead candidate acalabrutinib (ACP-196) is a second-generation, irreversible inhibitor of Bruton's tyrosine kinase (Btk) – a molecule deliberately ...

The FDA is to give AstraZeneca’s cancer drug acalabrutinib a fast review in a rare blood cancer, as the company hopes to shake off disappointing results from a crucial lung cancer trial last week.

Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a malignancy where the first-generation drug ibrutinib (Imbruvica) failed.

This finding is most noticeable in those taking a BTKi drug such as ibrutinib or acalabrutinib. Previous evidence from observational studies suggested that pausing the BTKi drug around the time of ...

This finding is most noticeable in those taking a BTKi drug such as ibrutinib or acalabrutinib. Previous evidence from observational studies suggests that pausing the BTKi drug around the time of ...